Serina Therapeutics, Inc. (SER): debt financing — AgeX draws $500K under secured convertible note with Juvenescence; due Feb 14, 2024

Serina Therapeutics, Inc.

Drew $500,000 on Jan 3, 2024 from Amended and Restated Secured Convertible Promissory Note.
Lender is Juvenescence Limited; repayment date set as February 14, 2024.
Other terms incorporated by reference from Nov 14, 2023 Form 10-Q.
Total outstanding under the note not disclosed in this filing.

item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Serina Therapeutics, Inc. incurred convertible notes of $500,000 with Juvenescence Limited maturing February 14, 2024.

Instrument: convertible notes
Principal: $500,000
Counterparty: Juvenescence Limited
Maturity: February 14, 2024
Event: incurrence

Exact text from the filing

On January 3, 2024, AgeX drew $500,000 of its credit available under the Amended and Restated Secured Convertible Promissory Note, as amended, (“Secured Note”) with Juvenescence Limited (“Juvenescence”).

View on SEC.gov

283 debt financings filed in the last 30 days. Browse all debt financings →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-001398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.